Found: 5
Select item for more details and to access through your institution.
Downstream Signaling of Inflammasome Pathway Affects Patients' Outcome in the Context of Distinct Molecular Breast Cancer Subtypes.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 6, p. 651, doi. 10.3390/ph15060651
- By:
- Publication type:
- Article
The Biological Relevance of NHERF1 Protein in Gynecological Tumors.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.836630
- By:
- Publication type:
- Article
Prognostic Value of NLRP3 Inflammasome and TLR4 Expression in Breast Cancer Patients.
- Published in:
- Frontiers in Oncology, 2021, v. 12, p. 1, doi. 10.3389/fonc.2021.705331
- By:
- Publication type:
- Article
NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01587
- By:
- Publication type:
- Article
Somatostatin Receptors in Merkel-Cell Carcinoma: A Therapeutic Opportunity Using Somatostatin Analog Alone or in Association With Checkpoint Inhibitors Immunotherapy. A Case Report.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.01073
- By:
- Publication type:
- Article